12 Health Care Stocks Moving In Thursday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Thursday's after-market session, several healthcare stocks showed significant movement. Telesis Bio and Maravai LifeSciences were among the top gainers, with Telesis Bio's shares soaring by 114.3% and Maravai LifeSciences by 17.41%, following their Q4 earnings reports. On the downside, GeneDx Hldgs and Penumbra experienced notable declines, with their stocks falling by 15.1% and 10.54% respectively, also influenced by their Q4 earnings outcomes.

February 22, 2024 | 9:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Penumbra's shares fell 10.54% to $235.0, with a market cap of $9.0 billion, influenced by their Q4 earnings report.
Penumbra's stock price decline is likely due to negative investor sentiment following their Q4 earnings announcement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
GeneDx Hldgs' stock fell 15.1% to $6.96, with a market cap of $180.2 million, following their Q4 earnings report released two days ago.
The decline in GeneDx Hldgs' stock price is likely due to negative investor reaction to their Q4 earnings report.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Maravai LifeSciences' shares increased by 17.41% to $6.0, with a market value of $793.1 million following their Q4 earnings report.
Maravai LifeSciences' stock price rose significantly, likely due to positive investor response to their Q4 earnings report.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Telesis Bio's shares surged 114.3% to $0.97, with a market value of $29.0 million.
The significant surge in Telesis Bio's stock price is likely due to positive investor reaction to their latest financial results or other favorable news.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90